Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oliceridine vs Sufentanil in Outpatient Hysteroscopy
NCT07713134Completed
- Sponsor
- Tangshan Maternal and Child Health Hospital
- Start
- Aug 2025
- Primary completion
- May 2026
- Countries
- 1
01
Overview
Trial of oliceridine in procedural pain (2 arms), sponsored by Tangshan Maternal and Child Health Hospital. Primary endpoints: Heart Rate, Mean Arterial Pressure and 1 more. Started Aug 2025; status: completed.
02
Drugs
oliceridine
03
Conditions
procedural pain
Beyond the preview
Go deeper on NCT07713134.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07713134.